1. Home
  2. PFSA vs EQS Comparison

PFSA vs EQS Comparison

Compare PFSA & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • EQS
  • Stock Information
  • Founded
  • PFSA 2009
  • EQS 1991
  • Country
  • PFSA United States
  • EQS United States
  • Employees
  • PFSA N/A
  • EQS N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • EQS Finance Companies
  • Sector
  • PFSA Health Care
  • EQS Finance
  • Exchange
  • PFSA Nasdaq
  • EQS Nasdaq
  • Market Cap
  • PFSA 25.1M
  • EQS 20.1M
  • IPO Year
  • PFSA N/A
  • EQS N/A
  • Fundamental
  • Price
  • PFSA $0.40
  • EQS $2.07
  • Analyst Decision
  • PFSA
  • EQS
  • Analyst Count
  • PFSA 0
  • EQS 0
  • Target Price
  • PFSA N/A
  • EQS N/A
  • AVG Volume (30 Days)
  • PFSA 6.6M
  • EQS 87.3K
  • Earning Date
  • PFSA 08-14-2025
  • EQS 01-01-0001
  • Dividend Yield
  • PFSA N/A
  • EQS N/A
  • EPS Growth
  • PFSA N/A
  • EQS N/A
  • EPS
  • PFSA N/A
  • EQS N/A
  • Revenue
  • PFSA $75,000.00
  • EQS $1,355,000.00
  • Revenue This Year
  • PFSA N/A
  • EQS N/A
  • Revenue Next Year
  • PFSA N/A
  • EQS N/A
  • P/E Ratio
  • PFSA N/A
  • EQS N/A
  • Revenue Growth
  • PFSA 66.67
  • EQS 60.35
  • 52 Week Low
  • PFSA $0.38
  • EQS $0.74
  • 52 Week High
  • PFSA $5.50
  • EQS $2.11
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • EQS 81.36
  • Support Level
  • PFSA N/A
  • EQS $1.82
  • Resistance Level
  • PFSA N/A
  • EQS $2.09
  • Average True Range (ATR)
  • PFSA 0.00
  • EQS 0.09
  • MACD
  • PFSA 0.00
  • EQS 0.01
  • Stochastic Oscillator
  • PFSA 0.00
  • EQS 94.87

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

Share on Social Networks: